CONTX ContextVision AB

ContextVision stock-based incentive program - share transactions

ContextVision stock-based incentive program - share transactions

Stockholm, March 29, 2021

The ContextVision AB:s Profit Sharing Foundation has sold and purchased shares in ContextVision AB in accordance with the rules related to the foundation.

The ContextVision AB:s Profit Sharing Foundation has sold 154,200 shares on March 19, at an average price of 20 NOK/share, in accordance with the rules related to the foundation. The sold shares were originally purchased in 2016, and according to the rules they must be sold after a period of 3 full calendar years, the year of purchase thereby not included. The net contribution after tax deductions, will be paid out to the employees.

The company achieved important goals during 2020 related to sales and new customers within the core business of image enhancement. As a result, SEK 202,000 were allocated to the foundation, and after tax deduction SEK 162,562 were transferred to the foundation. The foundation thereafter purchased 7,900 shares on March 29, at the average price of 20,05 NOK/share.

The ContextVision AB:s Profit Sharing Foundation's total ownership after the transactions is now 159,800 shares.

Background:

In 2011, the board and management of ContextVision decided to introduce an incentive program through the creation of a profit-sharing foundation for its employees.

The program is intended to streamline the focus and efforts of all employees by allocating a part of the company's net profits to a foundation that, in turn, will use the allocated funds to purchase ContextVision's common stock on the Oslo Stock Exchange.

Senior management and the board of directors will each year formulate a number of operational and strategic targets to be achieved during the coming fiscal year.

According to the rules of the foundation, the shares bought each year will be kept for a period of 3 full calendar years. After that period, the shares will be sold and funds (less tax) will be paid to the employees.

For further information, please contact CFO Ann-Charlotte Linderoth,

e-mail:



This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

Attachment



EN
29/03/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ContextVision AB

 PRESS RELEASE

NOTICE TO EXTRAORDINARY GENERAL MEETING IN CONTEXTVISION AB (PUBL)

NOTICE TO EXTRAORDINARY GENERAL MEETING IN CONTEXTVISION AB (PUBL) The shareholders of ContextVision AB, corporate registration number 556377-8900, are hereby invited to attend an extraordinary general meeting on the 10 December, 2021 at 10 a.m CET at ContextVision AB's office, Klara Norra Kyrkogata 31, 111 22, Stockholm. Right to participate and notification Shareholders who wish to participate in the annual general meeting with the right to vote shall be entered in the share register kept by Euroclear Sweden AB as of Thursday, 2 December 2021, and give notice of attendance to the co...

 PRESS RELEASE

Kallelse till extra bolagsstämma i ContextVision AB (Publ)

Kallelse till extra bolagsstämma i ContextVision AB (Publ) Aktieägarna i ContextVision AB, org. nr. 556377-8900, kallas härmed till extra bolagsstämma fredagen den 10 december 2021 kl. 10.00 på ContextVision AB:s kontor, Klara Norra Kyrkogata 31, 111 22, Stockholm. Rätt att delta och anmälan Aktieägare som önskar delta i bolagsstämman ska vara införd i den av Euroclear Sweden AB förda aktiebok torsdagen den 2 december 2021, ochskriftligen anmäla sig till bolaget senast fredagen den 3 december 2021. Anmälan görs via e-post till eller post till Klara Norra Kyrkogata 31, 111 22 Sto...

 PRESS RELEASE

ContextVision to focus pathology efforts on the establishment of a ful...

ContextVision to focus pathology efforts on the establishment of a fully AI-supported lab service STOCKHOLM – Nov 15, 2021 - ContextVision, a medical technology software company specializing in image processing and decision support tools within digital pathology, today announces that the Board of Directors of ContextVision has decided to make a strategic shift and focus its pathology business unit entirely on the establishment of an AI based pathology lab service. The updated strategy means that the company will continue to develop its machine learning technology for its own laboratory ...

 PRESS RELEASE

ContextVision vil fokusere patologiinnsatsen på etableringen av en ful...

ContextVision vil fokusere patologiinnsatsen på etableringen av en fullt AI-støttet laboratorietjeneste STOCKHOLM – 15 november 2021 – ContextVision, et medisinsk teknologiselskap som spesialiserer seg på bildebehandling, har styret i dag vedtatt et strategisk skifte hvor hele patologivirksomheten nå skal fokusere på å etablere en AI-basert patologilaboratorietjeneste. Den oppdaterte strategien innebærer at selskapet fortsatt vil utvikle sin maskinlæringsteknologi, men nå for sin egen laboratorietjeneste, og gi slipp på dagens forretningsstrategi om å utvikle og selge beslutningsstøtteverk...

 PRESS RELEASE

ContextVision – Mandatory notification of trade – primary insider

ContextVision – Mandatory notification of trade – primary insider STOCKHOLM – October 22, 2021 – Fredrik Palm, CEO of ContextVision, has on October 22nd, 2021 purchased 2,500 shares in ContextVision AB at an average price of NOK 22.47 per share. After the transaction, Mr Palm holds a total of 30,700 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction: Name of listed entity: ContextVision ABISIN number: SE0014731154 Stock ticker: CONTX Name of primary insider: Fredrik PalmRel...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch